Strategic Focus Target healthcare and related sectors with an opportunistic long/short equity approach, presenting a clear value proposition for portfolio diversification and alpha through specialized sector knowledge.

Recent Activism Active stake acquisitions in mid to late 2024 and into 2025 across Apellis Pharmaceuticals, Schrödinger, Glaukos, Medpace, and Globus Medical indicate ongoing deployment of capital in healthcare growth names, signaling potential for co-investor syndication and advisory opportunities.

Fundraising Signals Revenue range and lean team size suggest opportunistic capital deployment with potential appetite for scalable investment solutions, partnerships, or fund-of-funds collaborations to leverage their healthcare thesis.

Technology Footprint Tech stack includes modern web and data tools (Squarespace, JSON-LD, Office 365) that facilitate fast outreach and reporting; consider offering top-tier fintech data services, compliance-ready analytics, and investor-tailored dashboards.

Competitive Positioning As a small but active player in a field dominated by large managers, Iron Triangle Partners may value strategic services such as fund administration, regulatory compliance, risk analytics, and specialized healthcare research to scale operations and improve performance.